| 1 |
SANOFI GENZYME Web. Available at: https://www.thyrogen.com/patients/About-Thy rogen/What-is-Thyrogen.aspx February 2018./
|
|
| 2 |
강용길, TEXTBOOK OF NUCLEAR MEDICINE, 청구문화사, 2018/
|
|
| 3 |
Saint-Aubert L., Lemoine L., Chiotis K., Leuzy A., Rodriguez-Vieitez E., Nordberg A., Tau PET imaging: present and future directions. Mol Neurodegener. 2017;12:19./
|
|
| 4 |
Furuta A, Onishi H, Kangai Y, Shigehiro Y, Kawasaki. Effect of Scatter Limitation Correction with Misregistration between Computed Tomography and Positron Emission Tomography on Scatter Correction: A Physical Phantom Study. JSRT. 2017_73.3.185./
|
|
| 5 |
M. Ricard , S. Grimaldi M. Terroir et al. Quantification en TEMP/TDM, logiciel Q.Metrix & $^{99m}Tc$-MAA. Medecine nucleaire, hopital universitaire Gustave-Roussy, Villejuif, Imagerie therapeutique, hopital universitaire Gustave-Roussy, Villejuif, France. Medecine Nucleaire 40 (2016) 169-185 O_33./
|
|
| 6 |
Harada R., Okamura N., Furumoto S., et al., $^{18}F$-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in alzheimer disease. J Nucl Med. 2016;57:208-214./
|
|
| 7 |
Miwa K, Umeda T, Murata T, Wagatsuma K, Miyaji N, Terauchi T, Koizumi M, Sasaki M.Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging. Nucl Med Commun. 2016 Feb; 37(2):147-54./
|
|
| 8 |
Okamura N, Harada R, Furukawa K, Furumoto S, Tago T, Yanai K, et al. Advances in the development of tau PET radiotracers and their clinical applications. Ageing Res Rev. 2016;30:107-13./
|
|
| 9 |
Ayano Makita, Naoya Matsumoto, Yasuyuki Suzuki, et. al. Clinical Feasibility of Simultaneous Acquisition Rest $^{99m}Tc$/Stress 201Tl Dual-Isotope Myocardial Perfusion Single-Photon Emission Computed Tomography With Semiconductor Camera. Circulation Journal. Published online: 18 January 2016./
|
|
| 10 |
DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv 2016;2:e1600200./
|
|